RNA-Based Therapeutics: Current Developments in Targeted Molecular Therapy of Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is a highly heterogeneous and aggressive cancer that has the highest mortality rate out of all breast cancer subtypes. Conventional clinical treatments targeting ER, PR, and HER2 receptors have been unsuccessful in the treatment of TNBC, which has led to various...

Descripción completa

Detalles Bibliográficos

Autores principales:	Sakib Haque, Kiri Cook, Gaurav Sahay, Conroy Sun
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2021-10-01
Colección:	Pharmaceutics
Materias:	triple-negative breast cancer RNA interference small interfering RNA microRNA messenger RNA gene silencing
Acceso en línea:	https://www.mdpi.com/1999-4923/13/10/1694
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!